IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent/recurrent disease in papillary thyroid carcinoma with/without Hashimoto's thyroiditis

References

• Sherman SI. Thyroid carcinoma. Lancet 2003;361:501–11.
   PubMed Web of Science ®Google Scholar
• Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. AMA Arch Surg 1955;70:291–7.
   PubMedGoogle Scholar
• Rago T, Di Coscio G, Ugolini C, Scutari M, Basolo F, Latrofa F, Romani R, Berti P, Grasso L, Braverman LE, Pinchera A, Vitti P. Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy. Clin Endocrinol (Oxf) 2007;67:363–9.
   PubMed Web of Science ®Google Scholar
• Zenewicz LA, Abraham C, Flavell RA, Cho JH. Unraveling the genetics of autoimmunity. Cell 2010;140:791–7.
   PubMed Web of Science ®Google Scholar
• Singh B, Shaha AR, Trivedi H, Carew JF, Poluri A, Shah JP. Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome. Surgery 1999;126:1070–7.
   PubMed Web of Science ®Google Scholar
• Benvenga S. On the association between Hashimoto's thyroiditis and papillary thyroid carcinoma: looking 100 years back and, hopefully, fewer years ahead to sort out this association. Thyroid 2013;23:1180–1.
   PubMed Web of Science ®Google Scholar
• Kebebew E, Treseler PA, Ituarte PHG, Clark OH. Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg 2001;25:632–7.
   PubMed Web of Science ®Google Scholar
• Muzza M, Degl’Innocenti D, Colombo C, Perrino M, Ravasi E, Rossi S, Cirello V, Beck-Peccoz P, Borrello MG, Fugazzola L. The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies. Clin Endocrinol 2010;72:702–8.
   PubMed Web of Science ®Google Scholar
• Antonelli A, Ferrari SM, Fallahi P, Frascerra S, Piaggi S, Gelmini S, Lupi C, Minuto M, Berti P, Benvenga S, Basolo F, Orlando C, Miccoli P. Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists. Endocr Relat Cancer 2009;16:1299–311.
   PubMed Web of Science ®Google Scholar
• Pacifico F, Leonardi A. Role of NF-κB in thyroid cancer. Mol Cell Endocrinol 2010;321:29–35.
   PubMed Web of Science ®Google Scholar
• Fiore E, Rago T, Latrofa F, Provenzale MA, Piaggi P, Delitala A, Scutari M, Basolo F, Di Coscio G, Grasso L, Pinchera A, Vitti P. Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine. Endocr Relat Cancer 2011;18:429–37.
   PubMed Web of Science ®Google Scholar
• Feldt-Rasmussen U, Verburg FA, Luster M, Cupini C, Chiovato L, Duntas L, Elisei R, Rimmele H, Seregni E, Smit JW, Theimer C, Giovanella L. Thyroglobulin autoantibodies as surrogate biomarkers in the management of patients with differentiated thyroid carcinoma. Curr Med Chem 2014; 21:3687–92.
   PubMed Web of Science ®Google Scholar
• Zaletel K, Gaberscek S. Hashimoto's thyroiditis: from Genes to the disease. Curr Genomics 2011;12:576–88.
   PubMed Web of Science ®Google Scholar
• Lumachi F, Basso SM, Orlando R. Cytokines, thyroid diseases and thyroid cancer. Cytokine 2010;50:229–33.
   PubMed Web of Science ®Google Scholar
• Todaro M, Zerilli M, Ricci-Vitiani L, Bini M, Perez Alea M, Maria Florena A, Miceli L, Condorelli G, Bonventre S, Di Gesu G, De Maria R, Stassi G. Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells. Cancer Res 2006;66:1491–9.
   PubMed Web of Science ®Google Scholar
• Mahmoud FA, Rivera NI.The role of C-reactive protein as a prognostic indicator in advanced cancer. Curr Oncol Rep 2002;4:250–5.
   PubMedGoogle Scholar
• Groblewska M, Mroczko B, Wereszczyska-Siemiatkowska U, Kedra B, Lukaszewicz M, Baniukiewicz A, Szmitkowski M. Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients. Clin Chem Lab Med 2008;46:1423–8.
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Kambouromiti G, Pitsiava D, Tsousou P, Tsiarkatsi M, Kartalis G. Serum C-reactive protein (CRP) levels in cancer patients are linked with tumor burden and are reduced by anti-hypertensive medication. Inflammation 2009;32:169–75.
   PubMed Web of Science ®Google Scholar
• Heikkilä K, Harris R, Lowe G, Rumley A, Yarnell J, Gallacher J, Ben-Shlomo Y, Ebrahim S, Lawlor DA. Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis. Cancer Causes Control 2009;20:15–26.
   PubMed Web of Science ®Google Scholar
• Johnson NA, Tublin ME. Postoperative surveillance of differentiated thyroid carcionoma: rationale, techniques and controversies. Radiology 2008;249:42–44.
   Web of Science ®Google Scholar
• Sturgeon C, Angelos P. Identification and treatment of aggressive thyroid cancers. Part 1: subtypes. Oncology (Williston Park)2006;20:253–60.
   Google Scholar
• Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 2006;154:787–803.
   PubMed Web of Science ®Google Scholar
• Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ. Revised American Thyroid Association Management Guidelines for patients with thyroid nodules and differentiated thyroid cancer. The American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2009;19:1167–2014.
   PubMed Web of Science ®Google Scholar
• Regalbuto C, Buscema M, Arena S, Vigneri R, Squatrito S, Pezzino V. False-positive findings on 131I whole-body scans because of posttraumatic superficial scabs. J Nucl Med 2002;43:207–9.
   PubMed Web of Science ®Google Scholar
• Shapiro B, Rufini V, Jarwan A, Geatti O, Kearfott KJ, Fig LM, Kirkwood ID, Gross MD. Artifacts, anatomical and physiological variants, and unrelated diseases that might cause false-positive whole-body 131-I scans in patients with thyroid cancer. Semin Nucl Med 2000;30:115–32.
   PubMed Web of Science ®Google Scholar
• Sisson JC, Freitas J, McDougall IR, Dauer LT, Hurley JR, Brierley JD, Edinboro CH, Rosenthal D, Thomas MJ, Wexler JA, Asamoah E, Avram AM, Milas M, Greenlee C. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I: practice recommendations of the American Thyroid Association, The American Thyroid Association Taskforce on Radioiodine Safety. Thyroid 2011;21:335–46.
   PubMed Web of Science ®Google Scholar
• Lloyd RV, Buehler D, Khanafshar E. Papillary thyroid carcinoma variants. Head Neck Pathol 2011;5:51–6.
   PubMedGoogle Scholar
• Robbins RJ, Chon JT, Fleisher M, Larson SM, Tuttle RM. Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma? J Clin Endocrinol Metab 2002;87:3242–7.
   PubMed Web of Science ®Google Scholar
• Linnet K, Bossuyt PMM, Moons KGM, Reitsma JBR. Quantifying the accuracy of a diagnostic test or marker. Clin Chem 2012;58:1292–301.
   PubMed Web of Science ®Google Scholar
• Lin JD. Thyroglobulin and human thyroid cancer. Clin Chim Acta 2008;388:15–21.
   PubMed Web of Science ®Google Scholar
• Jeong JS, Kim HK, Lee CR, Park S, Park JH, Kang SW, Jeong JJ, Nam KH, Chung WY, Park CS. Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome. Korean Med Sci 2012;27:883–9.
   Web of Science ®Google Scholar
• Fiore E, Rago T, Latrofa F, Provenzale MA, Piaggi P, Delitala A, Scutari M, Basolo F, Di Coscio G, Grasso L, Pinchera A, Vitti P. Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine. Endocr Relat Cancer 2011;18:429–37.
   PubMed Web of Science ®Google Scholar
• Konturek A, Barczynski M, Nowak W, Wierzchowski W. Risk of lymph node metastases in multifocal papillary thyroid cancer associated with Hashimoto's thyroiditis. Langenbecks Arch Surg 2014;399:229–3.
   PubMed Web of Science ®Google Scholar
• Souza SL, Montalli da Assumpcao LV, Ward LS. Impact of previous thyroid autoimmune diseases on prognosis of patients with well-differentiated thyroid cancer. Thyroid 2003;13:491–5.
   PubMed Web of Science ®Google Scholar
• Kim EY, Kim WG, Kim WB, Kim TY, Kim JM, Ryu JS, Hong SJ, Gong G, Shong YK. Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma. Clin Endocrinol 2009;71:581–6.
   PubMed Web of Science ®Google Scholar
• Baudin E, Do Cao C, Cailleux AF, Leboulleux S, Travagli JP, Schlumberger M. Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients. J Clin Endocrinol Metab 2003;88:1107–11.
   PubMed Web of Science ®Google Scholar
• Mazzaferri EL. Will highly sensitive Thyroglobulin assays change the management of thyroid cancer? Clin Endocrinol 2007;67:321–3.
   PubMed Web of Science ®Google Scholar
• Stassi G, Todaro M, Zerilli M, Ricci-Vitiani L, Di Liberto D, Patti M, Florena A, Di Gaudio F, Di Gesu G, De Maria R. Thyroid cancer resistance to chemotherapeutic drugs via autocrine production of interleukin-4 and interleukin-10. Cancer Res 2003;63:6784–90.
   PubMed Web of Science ®Google Scholar
• Mazziotti G, Sorvillo F, Naclerio C, Farzati A, Cioffi M, Perna R, Valentini G, Farzati B, Amato G, Carella C. Type-1 response in peripheral CD4 + and CD8 + T cells from patients with Hashimoto's thyroiditis. Eur J Endocrinol 2003;148:383–8.
   PubMed Web of Science ®Google Scholar
• Gerenova J, Manolova I, Gadjeva V. Hashimoto's disease – involvement of cytokine network and role of oxidative stress in the severity of hashimoto's thyroiditis. In: Drahomira Springer, editor. A new look at hypothyroidism. InTech, 2012. pp. 91–124. DOI: 10.5772/30779.
   Google Scholar